ArticleThe Korean journal of internal medicine2018

No benefit of hypomethylating agents compared to supportive care for higher risk myelodysplastic syndrome.

Sang Kyun Sohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.